1 of 10: The B.1.1.529 (omicron) Spike looks a whole lot like a 'polymutant' Spike experimentally generated to evade antibody responses from infection or vaccination, as noted by @theodora_nyc.

What does this portend for its immune escape properties?

2: @theodora_nyc and colleagues conducted a *super* cool experiment where they drew on their experiments to evolve Spike proteins that were resistant to polyclonal antibody responses, as well as data on escape mutations in natural variants of concern...

nature.com/articles/s4158…
3: ...to create a polymutant Spike with 20 amino acid mutations from Wuhan/Hu-1.

There was undetectable neutralization of this mutant in the majority of plasma from both infected individuals and mRNA-vaccinated ones.
4: @theodora_nyc points out that omicron's Spike is similarly divergent to this experimental construct and *may* lead to substantial neutralization escape.

But on the bright side, her work shows that people who had been infected then vaccinated retained good neutralization...
5: ...against the polyvalent mutant.

So even if omicron is substantially more 'escapey' than previous variants, excellent neutralization may still be possible.
6: I speculate that a third dose of mRNA vaccines may afford similar or superior protection against polymutant Spike-bearing viruses as seen in 'infected-then-vaccinated' individuals in @theodora_nyc's experiments.
7: If so, it further underscores the *urgent* need to get serious about vaccine equity worldwide, with so many people still at 0 doses, let alone 3.
8: Lots of speculation in this thread. Caveat emptor.

But the cool thing is that within days we will have data on phenotypic properties like neutralization titers with this newly discovered variant.
9: The publication of the first SARS-CoV-2 genome by Zhang Yong-Zhen, with the help of @edwardcholmes, @arambaut and @virological_org, led to immediate progress on vaccines and diagnostics.

Similarly, the world-class genomic surveillance in southern Africa...
10: ...and immediate data sharing by @Tuliodna and colleagues, plus the evolutionary foundation built by @theodora_nyc, @jbloom_lab, @AllieGreaney, @tylernstarr etc. (see below), has put us in a position to understand this new variant at breakneck speed.

11 of 10: Important to add that T cell immunity and non-neutralization antibody responses are likely to provide considerable protection against severe disease and death even if omicron turns out to be a very serious neutralizing antibody escape variant.
*non-neutralizing
And my apologies to @PaulBieniasz, whose original idea of subjecting SARS-CoV-2 Spikes to the selective pressures of polyclonal Abs in plasma, laid the cornerstone of the evolutionary foundation I discuss above. h/t!
@PaulBieniasz Important: I put a link to @theodora_nyc and @PaulBieniasz's paper in Nature so that you can see that their polymutant Spike work was done with what are called pseudoviruses - harmless virus backbones that express the SARS-CoV-2 Spike, *not* SARS-CoV-2 itself.
Should say 'polymutant' not 'polyvalent' above😖

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Michael Worobey

Michael Worobey Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MichaelWorobey

27 Nov
1 of 9: Thank you SO MUCH @profvrr, Kathy Spindler, and @alandove for your excellent discussion of my recent COVID origins Perspective in @ScienceMagazine

science.org/doi/10.1126/sc…

on TWiV (This Week in Virology)
2: You hit on key points I wanted people to take home, especially that there really was a preponderance of early COVID cases linked to Huanan Market and this can't be dismissed as ascertainment bias (undue searching for cases linked to the market, while ignoring unlinked cases).
3: This, along with the fact that if the pandemic started there you should *expect* to see some cases unlinked to the market early on as people were infected then moved the virus into the nearby community, points squarely at the market as the overwhelmingly likely site of origin.
Read 10 tweets
19 Nov
Some follow-ups to this thread from yesterday about a Perspective article of mine, on early COVID cases in Wuhan, released by @ScienceMagazine :

First, I have learned that @franciscodeasis had earlier concluded that Mr. Chen, the so-called "Dec 8" patient, actually became ill on Dec 16:

And @Drinkwater5Reed and other DRASTIC members had advanced additional research along the same lines, including of the same news video I analyzed in my paper:

Read 15 tweets
19 Nov
I feel I must reply to a comment from @DavidRelman in a recent @nytimes article on a piece of mine in @ScienceMagazine on why a careful analysis of the earliest known cases in Wuhan indicate that the pandemic started at the Huanan Market.
“It is based on fragmentary information and to a large degree, hearsay,” David A. Relman, a professor of microbiology at Stanford University, said... “In general, there is no way of verifying much of what he describes, and then concludes.”
Here is the article, for those who would like to test David's dismissals against what I actually present in the piece. I do hope you'll do so.

science.org/doi/10.1126/sc…
Read 14 tweets
18 Nov
I wrote a Perspective on the origin of COVID just released in @ScienceMagazine

science.org/doi/10.1126/sc…
I have spent the last few months trying to poke holes in the hypothesis of a natural origin of SARS-CoV-2 by asking:

Was the apparent preponderance of early cases linked to Huanan Market real or just a mirage because that is where people were looking for cases?
This is a key question, because if the pattern is real, it is *very* hard to explain why we would observe it if the outbreak had not started at the market, in particular the western section where illegal wildlife like raccoon dogs was sold. It's about the size of a Home Depot.
Read 17 tweets
5 Nov
1/11 It's a great day! Pfizer's new SARS-CoV-2 antiviral cuts deaths by about 90%

But it's also a good time for a thread about the evolution of antiviral drug resistance.

apnews.com/article/corona…
2/ In 1987, FDA approved the first HIV antiviral, AZT. Hope quickly turned to despair though, because in patient after patient the virus quickly evolved to become resistant to AZT.

It wasn't until 1996 that the key breakthrough emerged.
3/ At a conference in Vancouver BC, researchers revealed that if patients were given "triple therapy", cocktails of drugs that attacked HIV in different ways, resistance could be averted.
Read 11 tweets
1 Oct
1/ Medium thread on #SARSCoV2's furin cleavage site and a strikingly similar region in some of the new BANAL genomes from Lao, and in RmYN02 from China.

Seems worth trying to clear up the confusion of @ydeigin on this issue (even it means broadcasting my pic, below).
2/ The furin cleavage site of SC2 is the RRAR in the NSPRRAR stretch of amino acids in the alignment I'm holding up there. It is what makes the virus 'pop' in humans.

The BANAL viruses have NSPAAR. A couple other ones, including RmYN02, have NSPAAR or NSPVAR.
3/ So, having barely scratched the surface of the genetic diversity of these viruses in the wild, we've found several that are literally a *single* amino acid away from having a furin cleavage site.

For example: (NSP) ->inserted R<- AAR.
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(